Website
Ratings & Metrics
Financial Documents
| Entity | Document Type | Tax ID |
|---|---|---|
| Engender Health, Inc. | Audited Financial Statements | 13-1623838 |
| Engender Health, Inc. | IRS Form 990 | 13-1623838 |
| Engender Health, Inc. | CHAR500 | 13-1623838 |
|
Entity: Engender Health, Inc. Document Type: Audited Financial Statements Tax ID: 13-1623838 |
|
Entity: Engender Health, Inc. Document Type: IRS Form 990 Tax ID: 13-1623838 |
|
Entity: Engender Health, Inc. Document Type: CHAR500 Tax ID: 13-1623838 |
Governance & Transparency
Top Salaries
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Traci Baird | President / CEO | $559,276 |
| 2 | Sekai Chikowero | Past VP of Program | $311,218 |
| 3 | Robyn Sneeringer | Chief of Staff | $301,103 |
|
1 Name: Traci Baird Title: President / CEO Compensation: $559,276 |
|
2 Name: Sekai Chikowero Title: Past VP of Program Compensation: $311,218 |
|
3 Name: Robyn Sneeringer Title: Chief of Staff Compensation: $301,103 |
Analysts' Notes
According to the EngenderHealth (EH) audit of June 30, 2025 (Note 12, Contingencies, U.S. Government Awards): "...On January 27, 2025, EngenderHealth received a stop-work order applicable to its United States Government funded programs. This directive was issued as a result of the Presidential Executive Order entitled “Reevaluating and Realigning United States Foreign Aid” which was issued on January 20, 2025, and mandates a 90-day pause in United States foreign development assistance for assessment of programmatic efficiencies and consistency with United States foreign policy. Subsequently, in February 2025, all of EngenderHealth's U.S. Government awards were terminated. Following the termination of EngenderHealth’s Federal awards in February 2025, the organization initiated the closeout process in alignment with Federal agency guidance. As of the date of this report, final approval of the closeout process remains pending. The ultimate determination of final balances to be paid to EngenderHealth (or refunded to donors) under such awards is contingent upon the outcome of the closeout process. EngenderHealth has assessed the financial and operational impact of this event, and it does not anticipate any immediate effects on other programs or funding sources. However, there is inherent uncertainty regarding the long term implications of the foreign aid terminations." |
According to the EngenderHealth (EH) tax filing for the fiscal year ended June 30, 2025, EH reports re: Compensation, Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (IRS Form 990, Schedule J, Part II): EH reports providing "bonus & incentive compensation" during 2024 to two individuals: 1) Traci Baird, President & CEO, received $81,400 of bonus and incentive compensation with total reported compensation of $559,276 2) Kathryn O'Connell, Senior Director of Technical Leadership, received $6,633 of bonus and incentive compensation with total reported compensation of $257,181. |